Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Diversity of Rotavirus Strains Circulating in Botswana before and after introduction of the Monovalent Rotavirus Vaccine.

Mokomane M, Esona MD, Bowen MD, Tate JE, Steenhoff AP, Lechiile K, Gaseitsiwe S, Seheri LM, Magagula NB, Weldegebriel G, Pernica JM, Mwenda JM, Kasvosve I, Parashar UD, Goldfarb DM.

Vaccine. 2019 Sep 14. pii: S0264-410X(19)31222-8. doi: 10.1016/j.vaccine.2019.09.022. [Epub ahead of print]

PMID:
31530468
2.

Timeliness of rotavirus vaccination at sentinel sites in four early-adopter African countries.

Pindyck T, Tate JE, Bonkoungou IJO, Armah G, Mujuru HA, Rugambwa C, Mwenda JM, Parashar U.

Vaccine. 2019 Sep 20;37(40):6002-6007. doi: 10.1016/j.vaccine.2019.08.008. Epub 2019 Aug 24.

PMID:
31455587
3.

Vaccine Effectiveness against DS-1-Like Rotavirus Strains in Infants with Acute Gastroenteritis, Malawi, 2013-2015.

Jere KC, Bar-Zeev N, Chande A, Bennett A, Pollock L, Sanchez-Lopez PF, Nakagomi O, Tate JE, Parashar UD, Heyderman RS, French N, Iturriza-Gomara M, Cunliffe NA.

Emerg Infect Dis. 2019 Sep;25(9):1734-1737. doi: 10.3201/eid2509.190258.

4.

Effectiveness of monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in Kenyan children.

Khagayi S, Omore R, Otieno GP, Ogwel B, Ochieng JB, Juma J, Apondi E, Bigogo G, Onyango C, Ngama M, Njeru R, Owor BE, Mwanga MJ, Addo Y, Tabu C, Amwayi A, Mwenda JM, Tate JE, Parashar UD, Breiman RF, Nokes DJ, Verani JR.

Clin Infect Dis. 2019 Jul 20. pii: ciz664. doi: 10.1093/cid/ciz664. [Epub ahead of print]

PMID:
31326980
5.

Rotavirus Vaccination Coverage During a Rotavirus Outbreak Resulting in a Fatality at a Subacute Care Facility.

Burke RM, Tate JE, Han GS, Quenelle R, Gautam R, Wadford DA, Bowen MD, Parashar UD.

J Pediatric Infect Dis Soc. 2019 Jul 18. pii: piz015. doi: 10.1093/jpids/piz015. [Epub ahead of print]

PMID:
31318031
6.

Current and new rotavirus vaccines.

Burke RM, Tate JE, Kirkwood CD, Steele AD, Parashar UD.

Curr Opin Infect Dis. 2019 Oct;32(5):435-444. doi: 10.1097/QCO.0000000000000572.

PMID:
31305493
7.

Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination - United States, 2000-2018.

Hallowell BD, Parashar UD, Curns A, DeGroote NP, Tate JE.

MMWR Morb Mortal Wkly Rep. 2019 Jun 21;68(24):539-543. doi: 10.15585/mmwr.mm6824a2.

8.

Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the Global Rotavirus Surveillance Network.

Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JNM, Cheikh D, Fahmy K, Teleb N, Ashmony HA, Ahmed H, Daniels DS, Videbaek D, Wasley A, Singh S, de Oliveira LH, Rey-Benito G, Sanwogou NJ, Wijesinghe PR, Liyanage JBL, Nyambat B, Grabovac V, Heffelfinger JD, Fox K, Paladin FJ, Nakamura T, Agócs M, Murray J, Cherian T, Yen C, Parashar UD, Serhan F, Tate JE, Cohen AL.

Lancet Glob Health. 2019 Jul;7(7):e893-e903. doi: 10.1016/S2214-109X(19)30207-4.

9.

Does Rotavirus Vaccination Affect Longer-Term Intussusception Risk in US Infants?

Burke RM, Tate JE, Dahl RM, Aliabadi N, Parashar UD.

J Pediatric Infect Dis Soc. 2019 Jun 14. pii: piz035. doi: 10.1093/jpids/piz035. [Epub ahead of print]

PMID:
31197368
10.

Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa.

Groome MJ, Tate JE, Arnold M, Chitnis M, Cox S, de Vos C, Kirsten M, le Grange SM, Loveland J, Machaea S, Maharaj A, Andrews N, Madhi SA, Parashar UD.

Clin Infect Dis. 2019 May 24. pii: ciz431. doi: 10.1093/cid/ciz431. [Epub ahead of print]

PMID:
31125061
11.

Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design.

Haber M, Lopman BA, Tate JE, Shi M, Parashar UD.

Vaccine. 2019 May 27;37(24):3229-3233. doi: 10.1016/j.vaccine.2019.04.065. Epub 2019 Apr 26.

PMID:
31036459
12.

Update on the global epidemiology of intussusception: a systematic review of incidence rates, age distributions and case-fatality ratios among children aged <5 years, before the introduction of rotavirus vaccination.

Clark AD, Hasso-Agopsowicz M, Kraus MW, Stockdale LK, Sanderson CFB, Parashar UD, Tate JE.

Int J Epidemiol. 2019 Mar 16. pii: dyz028. doi: 10.1093/ije/dyz028. [Epub ahead of print]

13.

Reduction of hospitalizations with diarrhea among children aged 0-5 years in Nouakchott, Mauritania, following the introduction of rotavirus vaccine.

Ahmed MC, Heukelbach J, Weddih A, Filali-Maltouf A, Sidatt M, Makhalla K, Dahdi S, Cheikh Ahmed AC, El-Mami MV, Tate JE, Parashar UD, Benhafid M.

Vaccine. 2019 Mar 7;37(11):1407-1411. doi: 10.1016/j.vaccine.2019.01.078. Epub 2019 Feb 11.

PMID:
30765173
14.

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?

Steele AD, Victor JC, Carey ME, Tate JE, Atherly DE, Pecenka C, Diaz Z, Parashar UD, Kirkwood CD.

Hum Vaccin Immunother. 2019;15(6):1215-1227. doi: 10.1080/21645515.2018.1553593. Epub 2019 Feb 8.

15.

Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination.

Hasso-Agopsowicz M, Ladva CN, Lopman B, Sanderson C, Cohen AL, Tate JE, Riveros X, Henao-Restrepo AM, Clark A; Global Rotavirus Surveillance Network and Rotavirus Age Study Collaborators .

Clin Infect Dis. 2019 Aug 30;69(6):1071-1078. doi: 10.1093/cid/ciz060.

16.

Factors Associated With Rotavirus Vaccine Coverage.

Aliabadi N, Wikswo ME, Tate JE, Cortese MM, Szilagyi PG, Staat MA, Weinberg GA, Halasa NB, Boom JA, Selvarangan R, Englund JA, Azimi PH, Klein EJ, Moffatt ME, Harrison CJ, Sahni LC, Stewart LS, Bernstein DI, Parashar UD, Payne DC.

Pediatrics. 2019 Feb;143(2). pii: e20181824. doi: 10.1542/peds.2018-1824. Epub 2019 Jan 17.

PMID:
30655333
17.

Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010-2013.

Omore R, Khagayi S, Ogwel B, Onkoba R, Ochieng JB, Juma J, Munga S, Tabu C, Kibet S, Nuorti JP, Odhiambo F, Mwenda JM, Breiman RF, Parashar UD, Tate JE.

BMC Infect Dis. 2019 Jan 11;19(1):47. doi: 10.1186/s12879-018-3615-6.

18.

Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe.

Mujuru HA, Burnett E, Nathoo KJ, Ticklay I, Gonah NA, Mukaratirwa A, Berejena C, Manangazira P, Rupfutse M, Weldegebriel GG, Mwenda JM, Yen C, Parashar UD, Tate JE.

Clin Infect Dis. 2018 Dec 23. doi: 10.1093/cid/ciy1096. [Epub ahead of print]

PMID:
30590488
19.

Approaches to monitoring intussusception following rotavirus vaccination.

Tate JE, Parashar UD.

Expert Opin Drug Saf. 2019 Jan;18(1):21-27. doi: 10.1080/14740338.2019.1561857. Epub 2018 Dec 26. Review.

PMID:
30570424
20.

Preparing for safety monitoring after rotavirus vaccine introduction - Assessment of baseline epidemiology of intussusception among children <2 years of age in four Asian countries.

Burnett E, Van Trang N, Rayamajhi A, Yousafzai MT, Satter SM, Anh DD, Thapa A, Qazi SH, Heffelfinger JD, Hung PH, Rayamajhi AK, Saddal N, Flora MS, Canh TM, Ali SA, Gurley ES, Tate JE, Yen C, Parashar UD.

Vaccine. 2018 Nov 29;36(50):7593-7598. doi: 10.1016/j.vaccine.2018.11.002. Epub 2018 Nov 7.

PMID:
30414781
21.

Post-licensure experience with rotavirus vaccination in Latin America and the Caribbean: a systematic review and meta-analysis.

Chavers T, De Oliveira LH, Parashar UD, Tate JE.

Expert Rev Vaccines. 2018 Nov;17(11):1037-1051. doi: 10.1080/14760584.2018.1541409. Epub 2018 Nov 7.

PMID:
30365904
22.

Intussusception after Rotavirus Vaccination in Africa.

Tate JE, Mwenda JM, Parashar UD.

N Engl J Med. 2018 Sep 27;379(13):1288-1289. doi: 10.1056/NEJMc1807645. No abstract available.

PMID:
30257154
23.

Effectiveness of monovalent rotavirus vaccine in the Philippines.

Lopez AL, Daag JV, Esparagoza J, Bonifacio J, Fox K, Nyambat B, Parashar UD, Ducusin MJ, Tate JE.

Sci Rep. 2018 Sep 24;8(1):14291. doi: 10.1038/s41598-018-32595-9.

24.

Diarrhea-Associated Mortality in Children Less Than 5 Years of Age in the United States, 2005-2016.

Aliabadi N, Pham H, Curns AT, Rha B, Tate JE, Parashar UD.

Pediatr Infect Dis J. 2019 Jul;38(7):e153-e154. doi: 10.1097/INF.0000000000002199.

PMID:
30239475
25.

Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction.

Cohen AL, Aliabadi N, Serhan F, Tate JE, Zuber P, Parashar UD.

Vaccine. 2018 Dec 14;36(51):7755-7758. doi: 10.1016/j.vaccine.2018.05.052. Epub 2018 Aug 18.

PMID:
30131194
26.

Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study.

Bar-Zeev N, King C, Phiri T, Beard J, Mvula H, Crampin AC, Heinsbroek E, Lewycka S, Tate JE, Parashar UD, Costello A, Mwansambo C, Heyderman RS, French N, Cunliffe NA; VacSurv Consortium.

Lancet Glob Health. 2018 Sep;6(9):e1036-e1044. doi: 10.1016/S2214-109X(18)30314-0. Erratum in: Lancet Glob Health. 2018 Dec;6(12):e1286.

27.

Safety monitoring of ROTAVAC vaccine and etiological investigation of intussusception in India: study protocol.

Reddy S, Nair NP, Giri S, Mohan VR, Tate JE, Parashar UD, Gupte MD, Arora R, Kang G; Indian Intussusception Surveillance Network.

BMC Public Health. 2018 Jul 20;18(1):898. doi: 10.1186/s12889-018-5809-7.

28.

Longer-term Direct and Indirect Effects of Infant Rotavirus Vaccination Across All Ages in the United States in 2000-2013: Analysis of a Large Hospital Discharge Data Set.

Baker JM, Tate JE, Steiner CA, Haber MJ, Parashar UD, Lopman BA.

Clin Infect Dis. 2019 Mar 5;68(6):976-983. doi: 10.1093/cid/ciy580.

PMID:
30020438
29.

A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness.

Haber M, Lopman BA, Tate JE, Shi M, Parashar UD.

Vaccine. 2018 Aug 9;36(33):5071-5076. doi: 10.1016/j.vaccine.2018.06.072. Epub 2018 Jul 3.

30.

Impact of rotavirus vaccines in Sub-Saharan African countries.

Mwenda JM, Parashar UD, Cohen AL, Tate JE.

Vaccine. 2018 Nov 12;36(47):7119-7123. doi: 10.1016/j.vaccine.2018.06.026. Epub 2018 Jun 18.

PMID:
29914848
31.

A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impact.

Pindyck T, Tate JE, Parashar UD.

Expert Rev Vaccines. 2018 Jul;17(7):593-606. doi: 10.1080/14760584.2018.1489724. Epub 2018 Jul 2. Review.

PMID:
29909693
32.

Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008-2015.

Simwaka JC, Mpabalwani EM, Seheri M, Peenze I, Monze M, Matapo B, Parashar UD, Mufunda J, Mphahlele JM, Tate JE, Mwenda JM.

Vaccine. 2018 Nov 12;36(47):7243-7247. doi: 10.1016/j.vaccine.2018.03.035. Epub 2018 Jun 12.

PMID:
29907481
33.

Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.

Bennett A, Pollock L, Jere KC, Pitzer VE, Parashar U, Tate JE, Heyderman RS, Mwansambo C, French N, Nakagomi O, Iturriza-Gomara M, Everett D, Cunliffe NA, Bar-Zeev N; VacSurv Consortium.

Vaccine. 2018 Nov 12;36(47):7142-7148. doi: 10.1016/j.vaccine.2018.04.030. Epub 2018 Jun 7.

34.

Sustained impact of rotavirus vaccine on rotavirus hospitalisations in Lusaka, Zambia, 2009-2016.

Mpabalwani EM, Simwaka JC, Mwenda JM, Matapo B, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7165-7169. doi: 10.1016/j.vaccine.2018.02.077. Epub 2018 May 21.

PMID:
29793891
35.

Rotavirus Vaccination Is Associated With Reduced Seizure Hospitalization Risk Among Commercially Insured US Children.

Burke RM, Tate JE, Dahl RM, Aliabadi N, Parashar UD.

Clin Infect Dis. 2018 Oct 30;67(10):1614-1616. doi: 10.1093/cid/ciy424.

PMID:
29788180
36.

Global rotavirus vaccine introductions and coverage: 2006 - 2016.

Abou-Nader AJ, Sauer MA, Steele AD, Tate JE, Atherly D, Parashar UD, Santosham M, Nelson EAS.

Hum Vaccin Immunother. 2018;14(9):2281-2296. doi: 10.1080/21645515.2018.1470725. Epub 2018 Jun 18.

37.

Impact of routine rotavirus vaccination on all-cause and rotavirus hospitalizations during the first four years following vaccine introduction in Rwanda.

Sibomana H, Rugambwa C, Mwenda JM, Sayinzoga F, Iraguha G, Uwimana J, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7135-7141. doi: 10.1016/j.vaccine.2018.01.072. Epub 2018 May 10.

PMID:
29754701
38.

Sustained impact of rotavirus vaccine introduction on rotavirus gastroenteritis hospitalizations in children <5 years of age, Ghana, 2009-2016.

Enweronu-Laryea CC, Armah G, Sagoe KW, Ansong D, Addo-Yobo E, Diamenu SK, Mwenda JM, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7131-7134. doi: 10.1016/j.vaccine.2018.02.058. Epub 2018 May 8.

PMID:
29752020
39.

Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: First evidence from a middle-income Asian country.

Lopez AL, Raguindin PF, Esparagoza J, Fox K, Batmunkh N, Bonifacio J, Parashar UD, Tate JE, Ducusin MJ.

Vaccine. 2018 May 31;36(23):3308-3314. doi: 10.1016/j.vaccine.2018.04.058. Epub 2018 May 3.

40.

Three Rotavirus Outbreaks in the Postvaccine Era - California, 2017.

Burke RM, Tate JE, Barin N, Bock C, Bowen MD, Chang D, Gautam R, Han G, Holguin J, Huynh T, Pan CY, Quenelle R, Sallenave C, Torres C, Wadford D, Parashar U.

MMWR Morb Mortal Wkly Rep. 2018 Apr 27;67(16):470-472. doi: 10.15585/mmwr.mm6716a3.

41.

Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.

Tate JE, Mwenda JM, Armah G, Jani B, Omore R, Ademe A, Mujuru H, Mpabalwani E, Ngwira B, Cortese MM, Mihigo R, Glover-Addy H, Mbaga M, Osawa F, Tadesse A, Mbuwayesango B, Simwaka J, Cunliffe N, Lopman BA, Weldegebriel G, Ansong D, Msuya D, Ogwel B, Karengera T, Manangazira P, Bvulani B, Yen C, Zawaira FR, Narh CT, Mboma L, Saula P, Teshager F, Getachew H, Moeti RM, Eweronu-Laryea C, Parashar UD; African Intussusception Surveillance Network.

N Engl J Med. 2018 Apr 19;378(16):1521-1528. doi: 10.1056/NEJMoa1713909.

42.

Distribution of rotavirus genotypes associated with acute diarrhoea in Zimbabwean children less than five years old before and after rotavirus vaccine introduction.

Mukaratirwa A, Berejena C, Nziramasanga P, Ticklay I, Gonah A, Nathoo K, Manangazira P, Mangwanya D, Marembo J, Mwenda JM, Weldegebriel G, Seheri M, Tate JE, Yen C, Parashar U, Mujuru H.

Vaccine. 2018 Nov 12;36(47):7248-7255. doi: 10.1016/j.vaccine.2018.03.069. Epub 2018 Apr 5.

PMID:
29628149
43.

Recurrent intussusception among infants less than 2 years of age in Vietnam.

Trang NV, Burnett E, Ly LH, Anh NP, Hung PH, Linh HM, Trang NCT, Canh TM, Minh VT, Tate JE, Yen C, Anh DD, Parashar UD.

Vaccine. 2018 Dec 14;36(51):7901-7905. doi: 10.1016/j.vaccine.2018.02.056. Epub 2018 Feb 23.

PMID:
29478753
44.

Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia.

Burnett E, Tate JE, Kirkwood CD, Nelson EAS, Santosham M, Steele AD, Parashar UD.

Expert Rev Vaccines. 2018 May;17(5):453-460. doi: 10.1080/14760584.2018.1443008. Epub 2018 Feb 26.

45.

Incidence and epidemiology of intussusception among children under 2 years of age in Chenzhou and Kaifeng, China, 2009-2013.

Liu N, Yen C, Huang T, Cui P, Tate JE, Jiang B, Parashar UD, Duan ZJ.

Vaccine. 2018 Dec 14;36(51):7862-7867. doi: 10.1016/j.vaccine.2018.02.032. Epub 2018 Feb 10.

PMID:
29439864
46.

Effect of Rotavirus Vaccination on Acute Diarrheal Hospitalizations Among Low and Very Low Birth Weight US Infants, 2001-2015.

Dahl RM, Curns AT, Tate JE, Parashar UD.

Pediatr Infect Dis J. 2018 Aug;37(8):817-822. doi: 10.1097/INF.0000000000001930.

47.

Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.

Tsolenyanu E, Djadou KE, Fiawoo M, Akolly DAE, Mwenda JM, Leshem E, Tate JE, Aliabadi N, Koudema W, Guedenon KM, Godonou M, Dagnra A, Gbadoe AD, Boko A, Landoh D, Atakouma Y, Parashar UD.

Vaccine. 2018 Nov 12;36(47):7185-7191. doi: 10.1016/j.vaccine.2018.01.058. Epub 2018 Feb 1.

PMID:
29397224
48.

Effect of Age at Vaccination on Rotavirus Vaccine Effectiveness in Bolivian Infants.

Burke RM, Tate JE, Pringle KD, Patel M, De Oliveira LH, Parashar UD.

Pediatr Infect Dis J. 2018 Aug;37(8):e216-e221. doi: 10.1097/INF.0000000000001907.

49.

Trends in Rate of Seizure-Associated Hospitalizations Among Children <5 Years Old Before and After Rotavirus Vaccine Introduction in the United Sates, 2000-2013.

Pringle KD, Burke RM, Steiner CA, Parashar UD, Tate JE.

J Infect Dis. 2018 Jan 30;217(4):581-588. doi: 10.1093/infdis/jix589.

PMID:
29325147
50.

Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.

Bonkoungou IJO, Aliabadi N, Leshem E, Kam M, Nezien D, Drabo MK, Nikiema M, Ouedraogo B, Medah I, Konaté S, Ouédraogo-Traoré R, Sangaré L, Kam L, Yé D, Ouattara M, Biey JN, Mwenda JM, Tate JE, Parashar UD.

Vaccine. 2018 Nov 12;36(47):7170-7178. doi: 10.1016/j.vaccine.2017.12.056. Epub 2017 Dec 28.

PMID:
29290478

Supplemental Content

Support Center